ACCESSION: MSBNK-SMB_Measured-HSA015P0158005
RECORD_TITLE: Characterized; N,N-dibutylformamide; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 52
COMMENT: RAW_SPEC {'EL03_pos_7118': {'bp': 172397.0, 'sum': 853472.0}, 'EL02_pos_7424': {'bp': 108377.0, 'sum': 721955.0}, 'EL02_pos_7607': {'bp': 119781.0, 'sum': 755988.0}, 'EL22_pos_7451': {'bp': 129167.0, 'sum': 816487.0}, 'EL03_pos_7064': {'bp': 156866.0, 'sum': 826023.0}, 'EL03_pos_7475': {'bp': 162178.0, 'sum': 721908.0}, 'Blanc2-pos_7263': {'bp': 73344.0, 'sum': 638888.0}, 'EL02_pos_7484': {'bp': 122907.0, 'sum': 753685.0}, 'EL03_pos_7280': {'bp': 161053.0, 'sum': 807968.0}, 'EL06_pos_7451': {'bp': 103233.0, 'sum': 710020.0}, 'EL03_pos_7389': {'bp': 154254.0, 'sum': 744041.0}, 'EL03_pos_7173': {'bp': 162878.0, 'sum': 827805.0}, 'EL05_pos_7407': {'bp': 110769.0, 'sum': 809129.0}, 'EL03_pos_7535': {'bp': 161635.0, 'sum': 709208.0}, 'EL03_pos_7334': {'bp': 156490.0, 'sum': 801797.0}, 'EL03_pos_7227': {'bp': 148088.0, 'sum': 766408.0}, 'Blanc1-pos_7990': {'bp': 136857.0, 'sum': 900448.0}, 'EL06_pos_7390': {'bp': 97956.0, 'sum': 748979.0}, 'EL19_pos_7420': {'bp': 113651.0, 'sum': 765656.0}, 'EL12_pos_7432': {'bp': 105623.0, 'sum': 743097.0}, 'EL05_pos_7480': {'bp': 103859.0, 'sum': 698089.0}, 'EL15_pos_7378': {'bp': 92089.0, 'sum': 713725.0}, 'EL21_pos_7432': {'bp': 89926.0, 'sum': 664206.0}, 'EL03_pos_7006': {'bp': 169372.0, 'sum': 790507.0}, 'EL12_pos_7371': {'bp': 110511.0, 'sum': 780601.0}, 'EL21_pos_7373': {'bp': 87908.0, 'sum': 705353.0}, 'EL16_pos_7412': {'bp': 79359.0, 'sum': 649285.0}, 'EL19_pos_7479': {'bp': 120843.0, 'sum': 775416.0}, 'EL15_pos_7439': {'bp': 94896.0, 'sum': 729633.0}, 'EL20_pos_7394': {'bp': 92343.0, 'sum': 688900.0}, 'EL17_pos_7355': {'bp': 86100.0, 'sum': 651783.0}, 'EL09_pos_7409': {'bp': 84945.0, 'sum': 696830.0}, 'EL09_pos_7349': {'bp': 83592.0, 'sum': 686500.0}, 'Blanc2-pos_7318': {'bp': 76526.0, 'sum': 638786.0}, 'EL11_pos_7388': {'bp': 73171.0, 'sum': 651410.0}, 'Blanc1-pos_7929': {'bp': 126664.0, 'sum': 975074.0}, 'EL16_pos_7352': {'bp': 79666.0, 'sum': 636754.0}, 'EL20_pos_7336': {'bp': 78154.0, 'sum': 623888.0}, 'EL10_pos_7335': {'bp': 76282.0, 'sum': 655999.0}, 'EL23_pos_7414': {'bp': 74091.0, 'sum': 644090.0}, 'EL04_pos_7343': {'bp': 70482.0, 'sum': 659910.0}, 'Blanc1-pos_7870': {'bp': 132470.0, 'sum': 859943.0}, 'EL07_pos_7504': {'bp': 89804.0, 'sum': 725079.0}, 'EL07_pos_7395': {'bp': 87187.0, 'sum': 697812.0}, 'EL13_pos_7353': {'bp': 78326.0, 'sum': 637356.0}, 'EL13_pos_7412': {'bp': 74844.0, 'sum': 643365.0}, 'EL18_pos_7348': {'bp': 69813.0, 'sum': 645640.0}, 'EL17_pos_7414': {'bp': 94995.0, 'sum': 716024.0}, 'EL08_pos_7403': {'bp': 80677.0, 'sum': 627291.0}, 'EL14_pos_7361': {'bp': 78687.0, 'sum': 686899.0}, 'EL08_pos_7343': {'bp': 80280.0, 'sum': 637806.0}, 'EL23_pos_7355': {'bp': 80513.0, 'sum': 700221.0}}
COMMENT: RETENTION_TIME_STDEV 0.188
COMMENT: PRECURSOR_M/Z_RAW 158.154160
COMMENT: PRECURSOR_M/Z_STDEV 0.000054
COMMENT: PRECURSOR_IN_MS1 mz 158.153986; int 53.161; delta(ppm) 0.945667
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.293; C9H19NO; [M+H]+; delta(ppm) 0.292720
COMMENT: PROPOSED_MF MS-FINDER 3.258; C9H19NO; [M+H]+; delta(ppm) 0.286636
COMMENT: PROPOSED_MF SIRIUS5_Sirius 11.822; C9H19NO; [M+H]+; delta(ppm) 0.286636
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C9H19NO; [M+H]+; delta(ppm) 0.286636
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.957; C9H19NO; [M+H]+; delta(ppm) 0.286636
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.136; C7H17N4; [M+H]+; delta(ppm) 8.776310
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C9H19NO; [M+H]+; delta(ppm) 0.286636
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.796; NZMAJUHVSZBJHL-UHFFFAOYSA-N; [M+H]+; CCCCN(CCCC)C=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.628; HHONKRXRGXJUCW-MDZDMXLPSA-N; [M+H]+; CCCCCCC\C(C)=N\O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.528; BPDCZYLPNNLOBD-UHFFFAOYSA-N; [M+H]+; O=C(NCC(C)C)CC(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.517; GHLZUHZBBNDWHW-UHFFFAOYSA-N; [M+H]+; CCCCCCCCC(N)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.514; QZMQDHNCNUGQSO-UHFFFAOYSA-N; [M+H]+; CCN(CC)C(=O)CC(C)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.223; HHONKRXRGXJUCW-MDZDMXLPSA-N; [M+H]+; UNPD143954
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.223; UYPVPBFQQUHERE-KTKRTIGZSA-N; [M+H]+; UNPD112415
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.223; WIXWMTMSISERBV-MDZDMXLPSA-N; [M+H]+; UNPD65027
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.195; VUZNLSBZRVZGIK-UHFFFAOYSA-N; [M+H]+; 1-hydroxy-2,2,6,6-tetramethylpiperidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.150; ICMNKCCFRUPZCU-UHFFFAOYSA-N; [M+H]+; 3-methyl-2-propylpentanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.140; QZMQDHNCNUGQSO-UHFFFAOYSA-N; [M+H]+; isovaleryl diethylamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.140; VDVUCLWJZJHFAV-UHFFFAOYSA-N; [M+H]+; 2,2,6,6-tetramethylpiperidin-4-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.088; BPDCZYLPNNLOBD-UHFFFAOYSA-N; [M+H]+; CNP0428582
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.082; KYEKSZMDGACCQD-BRJQIKQINA-N; [M+H]+; UNPD32313
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.075; GHLZUHZBBNDWHW-UHFFFAOYSA-N; [M+H]+; UNPD76164
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.065; QWDRYURVUDZKSG-VIFPVBQESA-N; [M+H]+; 1-Hydroxy-2-Amino-3-Cyclohexylpropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.046; YWFHDUFNGSJLTL-VIFPVBQESA-N; [M+H]+; N-1-Methylheptylformamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.042; DVJHWTLBEYCZJZ-SSEDHECMNA-N; [M+H]+; UNPD102291
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.042; ZRXAUOSECWYDMA-BRJQIKQINA-N; [M+H]+; UNPD140973
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.029; JOHKCJPJMSCFBX-BRJQIKQINA-N; [M+H]+; UNPD184071
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.023; NZMAJUHVSZBJHL-UHFFFAOYSA-N; [M+H]+; N,N-dibutylformamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.023; JFKADWNYKAZYSD-UHFFFAOYSA-N; [M+H]+; cis-azacyclodecan-5-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.018; MSYUGRASNIEUCW-MDWBIBFBNA-N; [M+H]+; UNPD26154
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; HHONKRXRGXJUCW-MDZDMXLPSA-N; [M+H]+; UNPD143954
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; UYPVPBFQQUHERE-KTKRTIGZSA-N; [M+H]+; UNPD112415
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; WIXWMTMSISERBV-MDZDMXLPSA-N; [M+H]+; UNPD65027
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.888; NZMAJUHVSZBJHL-UHFFFAOYSA-N; [M+H]+; N,N-dibutylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.888; BPDCZYLPNNLOBD-UHFFFAOYSA-N; [M+H]+; CNP0428582
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.847; DVJHWTLBEYCZJZ-SSEDHECMNA-N; [M+H]+; UNPD102291
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.844; QZMQDHNCNUGQSO-UHFFFAOYSA-N; [M+H]+; isovaleryl diethylamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.844; YWFHDUFNGSJLTL-VIFPVBQESA-N; [M+H]+; N-1-Methylheptylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.844; GHLZUHZBBNDWHW-UHFFFAOYSA-N; [M+H]+; UNPD76164
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.844; ICMNKCCFRUPZCU-UHFFFAOYSA-N; [M+H]+; 3-methyl-2-propylpentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.844; JOHKCJPJMSCFBX-BRJQIKQINA-N; [M+H]+; UNPD184071
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.844; MSYUGRASNIEUCW-MDWBIBFBNA-N; [M+H]+; UNPD26154
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.844; ZRXAUOSECWYDMA-BRJQIKQINA-N; [M+H]+; UNPD140973
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.844; JFKADWNYKAZYSD-UHFFFAOYSA-N; [M+H]+; cis-azacyclodecan-5-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.702; KYEKSZMDGACCQD-BRJQIKQINA-N; [M+H]+; UNPD32313
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.691; VDVUCLWJZJHFAV-UHFFFAOYSA-N; [M+H]+; 2,2,6,6-tetramethylpiperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.691; VUZNLSBZRVZGIK-UHFFFAOYSA-N; [M+H]+; 1-hydroxy-2,2,6,6-tetramethylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.671; QWDRYURVUDZKSG-VIFPVBQESA-N; [M+H]+; 1-Hydroxy-2-Amino-3-Cyclohexylpropane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.943; VUZNLSBZRVZGIK-UHFFFAOYSA-N; [M+H]+; 1-hydroxy-2,2,6,6-tetramethylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.051; NZMAJUHVSZBJHL-UHFFFAOYSA-N; [M+H]+; N,N-dibutylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.725; GHLZUHZBBNDWHW-UHFFFAOYSA-N; [M+H]+; nonanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.432; VDVUCLWJZJHFAV-UHFFFAOYSA-N; [M+H]+; 2,2,6,6-tetramethylpiperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.250; KWJAQKNXBIWDPO-UHFFFAOYSA-N; [M+H]+; [2-(2-methylpropyl)pyrrolidin-2-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.250; HJVRJOCKISGMLI-UHFFFAOYSA-N; [M+H]+; 2-(2-methylpropyl)oxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.249; MLSOMJXYSKJLAZ-UHFFFAOYSA-N; [M+H]+; 4-tert-butylpiperidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.249; SCFYAMLANWTHKN-UHFFFAOYSA-N; [M+H]+; 2-tert-butyloxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.249; HPKNTDCRBSNGEA-UHFFFAOYSA-N; [M+H]+; (2-tert-butyloxolan-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.249; RGBLJJXXWNGXMA-UHFFFAOYSA-N; [M+H]+; 2-(2-methylpropyl)oxan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.249; JIPFBCZZZJBRER-SFYZADRCSA-N; [M+H]+; [(2S,3R)-2-tert-butyloxolan-3-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.248; YZXDDIUXFGJNJN-UHFFFAOYSA-N; [M+H]+; 1-(dimethylamino)-4,4-dimethylpentan-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.195; JNSUUJLFWBSBME-UHFFFAOYSA-N; [M+H]+; 3-(2-methylpiperidin-1-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.178; HFHPBMVMXFZJNO-UHFFFAOYSA-N; [M+H]+; 1-(cyclohexylamino)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.156; NTYICSDTCGMBQM-UHFFFAOYSA-N; [M+H]+; N,N-bis(2-methylpropyl)formamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.151; QQBFZTKZYQFNHA-UHFFFAOYSA-N; [M+H]+; 1-tert-butylpiperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.117; GRGNJBKJCVOFEO-UHFFFAOYSA-N; [M+H]+; 5-(diethylamino)pentan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.114; INIIZXNMNKIITF-UHFFFAOYSA-N; [M+H]+; 3-amino-3-cyclohexylpropan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.114; LBKGSNPSDIYPBE-UHFFFAOYSA-N; [M+H]+; 2-[(dimethylamino)methyl]cyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.113; CZRCDRZKRJGHGB-UHFFFAOYSA-N; [M+H]+; 1-[(dimethylamino)methyl]cyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.113; UMQVSWNKTFNAEL-RKDXNWHRSA-N; [M+H]+; (1R,2R)-2-ethoxycycloheptan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.113; YHARJABDPGDVSR-RKDXNWHRSA-N; [M+H]+; [(1S,2R)-2-(dimethylamino)cyclohexyl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.109; VGNDMJNNNYAABM-UHFFFAOYSA-N; [M+H]+; 2-(aminomethyl)-3-cyclopentylpropan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.108; BJYNTHACALEJGC-UHFFFAOYSA-N; [M+H]+; 2-(3-aminopropyl)cyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.108; NCMLFEXUCUKLTC-UHFFFAOYSA-N; [M+H]+; 1-cyclohexyl-2-(methylamino)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.108; NCHRTQDYCCCDDN-UHFFFAOYSA-N; [M+H]+; (1-methoxycycloheptyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.108; FVKOSULHWWBPPZ-UHFFFAOYSA-N; [M+H]+; (1-methoxy-3-methylcyclohexyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.108; MOOLCUJJTYOPDX-UHFFFAOYSA-N; [M+H]+; 1-(methylaminomethyl)cycloheptan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.108; NNJGMUPZEXDYDP-UHFFFAOYSA-N; [M+H]+; 1-(2-aminoethyl)cycloheptan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.108; YPNXWVGJCIUHFJ-UHFFFAOYSA-N; [M+H]+; 2-(1-methoxycyclohexyl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.100; AOFZLQPFVNKHSR-UHFFFAOYSA-N; [M+H]+; 2-ethylheptanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.100; YECWYDXDKXESES-UHFFFAOYSA-N; [M+H]+; 2-(3-methoxypropyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.099; XMXJFWWVIWEVQJ-UHFFFAOYSA-N; [M+H]+; 3-(2-methoxyethyl)azepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.098; NBXAPOVFSGOATB-UHFFFAOYSA-N; [M+H]+; N-(2,4,4-trimethylpentan-2-yl)formamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.098; BJXJCAMLWINIQS-UHFFFAOYSA-N; [M+H]+; N-(2,2,4,4-tetramethylpentan-3-ylidene)hydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.098; HJXLFVPMOMDPNR-UHFFFAOYSA-N; [M+H]+; 2-ethyl-N-methylhexanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.097; AGCBBXPWJMYJGB-UHFFFAOYSA-N; [M+H]+; 2,2,4,4-tetramethylpentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.097; MXZJHUFPDPEROD-UHFFFAOYSA-N; [M+H]+; 2-ethyl-5-methylhexanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.096; RPPGMZVKEWPDGB-SECBINFHSA-N; [M+H]+; (3R)-3-(3-methylbutoxy)pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.096; WBYHBNSUFOOVLX-UHFFFAOYSA-N; [M+H]+; 1-(cyclopropylamino)-3,3-dimethylbutan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.096; JBLNCKGCJCTSOJ-UHFFFAOYSA-N; [M+H]+; 7-tert-butyl-1,4-oxazepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.096; GIGKHNPRTHOMSB-UHFFFAOYSA-N; [M+H]+; 2-tert-butyl-2-methylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.096; JOHKCJPJMSCFBX-UHFFFAOYSA-N; [M+H]+; 1-(1-methylpiperidin-2-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.096; PRQUQLLKNBALCZ-UHFFFAOYSA-N; [M+H]+; 2-(1-methylpiperidin-2-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.087; VQCDOLZOAYIDQJ-UHFFFAOYSA-N; [M+H]+; 4-(2-methylpropoxy)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.086; XGPJZKQGJWZWIM-UHFFFAOYSA-N; [M+H]+; 4-butoxypiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.086; VWXSCKOHAKPRKK-MRVPVSSYSA-N; [M+H]+; (2R)-2-[(2-methylpropan-2-yl)oxymethyl]pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.086; RSMXSKJUTTWWLA-UHFFFAOYSA-N; [M+H]+; 3-[(2-methylpropan-2-yl)oxy]piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.085; PTPWBTAUDLQZKV-UHFFFAOYSA-N; [M+H]+; N-[2-[(2-methylpropan-2-yl)oxy]ethyl]cyclopropanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.085; KBYASNMQYNVACB-HTQZYQBOSA-N; [M+H]+; (1R,2R)-2-[(2-methylpropan-2-yl)oxy]cyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.085; SREGPVVWLSESFC-UHFFFAOYSA-N; [M+H]+; 4-butan-2-yloxypiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.085; FVAFFSLNBGWGEQ-UHFFFAOYSA-N; [M+H]+; [3-[(2-methylpropan-2-yl)oxy]cyclobutyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.085; BCPWKBKIOFUMTD-JGVFFNPUSA-N; [M+H]+; [(1S,2R)-2-[(2-methylpropan-2-yl)oxy]cyclobutyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.076; CMAXLAQPCZHYRB-UHFFFAOYSA-N; [M+H]+; 6-methoxy-2,2-dimethylcyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.076; GJPRLMIJSXDNSB-UHFFFAOYSA-N; [M+H]+; 2-(aminomethyl)-4,4-dimethylcyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.075; OJHFXJYQQCFGOQ-UHFFFAOYSA-N; [M+H]+; 2-(3,3-dimethyloxan-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.075; COOJVMHRVYJJAH-UHFFFAOYSA-N; [M+H]+; 2-methyl-2-(oxan-2-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.073; RPCMANPQGDZWBI-UHFFFAOYSA-N; [M+H]+; 2-(5,5-dimethyloxan-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.070; HTNALYQLVYDBSI-UHFFFAOYSA-N; [M+H]+; (2-propan-2-yloxan-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.069; CHHKBQOLWAUFPM-UHFFFAOYSA-N; [M+H]+; N-ethyl-2,2-dimethyloxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.017; JKUFWRDSSYNRPE-NTMALXAHSA-N; [M+H]+; (NZ)-N-(3-propylhexan-2-ylidene)hydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.984; AUXMJHJWQFKJDJ-UHFFFAOYSA-N; [M+H]+; [1-(2-ethoxyethyl)cyclobutyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.972; LABJYIPPYWKIAD-UHFFFAOYSA-N; [M+H]+; (4-ethoxycyclohexyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.966; OVTMCBIZTDPCGB-UHFFFAOYSA-N; [M+H]+; 2,2-dimethyl-3-pyrrolidin-1-ylpropan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.965; SOHAWBMOFPPYDC-UHFFFAOYSA-N; [M+H]+; 2-methyl-4-pyrrolidin-1-ylbutan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.965; DAXQBFKMRFISCP-SECBINFHSA-N; [M+H]+; (2S)-3-methyl-2-pyrrolidin-1-ylbutan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.956; MVEHLQBURCSCQA-UHFFFAOYSA-N; [M+H]+; 1-(1-ethylpiperidin-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.947; KXFQCMKAQXWNSL-UHFFFAOYSA-N; [M+H]+; 3-(azepan-1-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.944; CHXUMKPVYHZWSN-UHFFFAOYSA-N; [M+H]+; (3-propan-2-ylpiperidin-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.944; SSBJNXYJAHFKJQ-UHFFFAOYSA-N; [M+H]+; 2-methyl-1-piperidin-1-ylpropan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.943; RHULHUMGLDCWCP-UHFFFAOYSA-N; [M+H]+; 1-(azepan-1-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.938; PIOUVJMSPKFDJZ-UHFFFAOYSA-N; [M+H]+; 3-methoxy-2,2,4,4-tetramethylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.935; RJRRWCVYXLMUJD-UHFFFAOYSA-N; [M+H]+; 4-amino-1-propan-2-ylcyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.932; QWDRYURVUDZKSG-VIFPVBQESA-N; [M+H]+; (2S)-2-amino-3-cyclohexylpropan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.926; DSDSZHUBHNTFNX-UHFFFAOYSA-N; [M+H]+; 2-[cyclohexyl(methyl)amino]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.925; ZRXXYJYSVHQULF-UHFFFAOYSA-N; [M+H]+; 3-cyclohexyloxypropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.925; DFOAUWHTDKZVPW-UHFFFAOYSA-N; [M+H]+; 3-(cyclohexylamino)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.924; WLNWJJLFZFNSAW-UHFFFAOYSA-N; [M+H]+; N-(2-methoxyethyl)cyclohexanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.923; OWSKYYMCKRWOEA-UHFFFAOYSA-N; [M+H]+; 1-cyclohexyl-N-ethoxymethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.923; MLZLVMCHKUSCQC-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)-3,3-dimethylcyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.923; NXBJSUOOKXVSFX-IUCAKERBSA-N; [M+H]+; (1S,2S)-2-(propan-2-ylamino)cyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.923; IGNIQYQEYLIVJD-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)-4,4-dimethylcyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.922; UKTBJVVCFQRSAE-UHFFFAOYSA-N; [M+H]+; N-(2-methoxyethyl)-3-methylcyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.922; WVAVJUUVJFWPJM-UHFFFAOYSA-N; [M+H]+; 2-(2-methylcyclohexyl)oxyethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.922; QXCAMZSWINJGLA-UHFFFAOYSA-N; [M+H]+; (1-amino-4-ethylcyclohexyl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.922; KBZZKXGGRZDEOS-UHFFFAOYSA-N; [M+H]+; N-(2-methoxyethyl)-2-methylcyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.922; LZBCDMOWRUZUJE-UHFFFAOYSA-N; [M+H]+; N-methyl-2-(1-methylcyclopentyl)oxyethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.917; PCQWQLYLZRJDLA-UHFFFAOYSA-N; [M+H]+; 2,2,6,6-tetramethyloxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.890; AAHIYAKUVPMLMX-UHFFFAOYSA-N; [M+H]+; 3-(diethylamino)-2,2-dimethylpropanal
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.873; OKDIVZDZOAXDQB-UHFFFAOYSA-N; [M+H]+; [1-(diethylaminomethyl)cyclopropyl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.873; CGCDPLMLTIOADD-UHFFFAOYSA-N; [M+H]+; N-methyl-2-propylpentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.862; KAACLWQGBIEOGR-UHFFFAOYSA-N; [M+H]+; 3-propylhexanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.861; MSRLXJWEQJQIJQ-UHFFFAOYSA-N; [M+H]+; N-(2-propylpentyl)formamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.834; RDFVLCNOBZQYRK-UHFFFAOYSA-N; [M+H]+; 2,2-dimethyl-3-propan-2-yloxycyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.812; SWHGGGURSFRRNJ-UHFFFAOYSA-N; [M+H]+; [1-(1-amino-2-methylpropyl)cyclobutyl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.805; LZXLHLSTUPFULX-UHFFFAOYSA-N; [M+H]+; (1-propan-2-ylpiperidin-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.805; FLKOJXQVRBGEES-UHFFFAOYSA-N; [M+H]+; (1-propan-2-ylpiperidin-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.786; MZUBANKASMUHHF-UHFFFAOYSA-N; [M+H]+; 4-propoxycyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.784; WKEDXGRBZXNJEX-UHFFFAOYSA-N; [M+H]+; 3-propan-2-yloxycyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -124.357; NBXAPOVFSGOATB; [M+H]+; tert-Octylformamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -139.422; BJXJCAMLWINIQS; [M+H]+; 2,2,4,4-Tetramethyl-3-pentanone oxime
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -141.891; NTYICSDTCGMBQM; [M+H]+; n,n-diisobutylformamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -143.138; QZMQDHNCNUGQSO; [M+H]+; Valimyl
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -144.034; AGCBBXPWJMYJGB; [M+H]+; 2,2,4,4-Tetramethylvaleramide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -152.903; MXZJHUFPDPEROD; [M+H]+; 2-Ethyl-5-methylhexanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -156.735; ICMNKCCFRUPZCU; [M+H]+; Sec-Butyl-Propylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -166.717; MSRLXJWEQJQIJQ; [M+H]+; n-(2-propylpentyl)formamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.545; HFHPBMVMXFZJNO; [M+H]+; 1-Cyclohexylaminopropan-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -184.490; VQCDOLZOAYIDQJ; [M+H]+; 4-(2-methylpropoxy)piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -186.568; KAACLWQGBIEOGR; [M+H]+; 3-Propylhexanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -188.580; VDVUCLWJZJHFAV; [M+H]+; Lastar A
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -192.706; VUZNLSBZRVZGIK; [M+H]+; 1-hydroxy-2,2,6,6-tetramethylpiperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -192.833; DVJHWTLBEYCZJZ; [M+H]+; 1-(6-methyl-2-piperidyl)propan-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -193.207; OCRWQOBBCGSFAT; [M+H]+; Oprea1_131312
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -193.833; HJXLFVPMOMDPNR; [M+H]+; 2-Ethyl-N-methylhexanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -195.777; YWFHDUFNGSJLTL; [M+H]+; N-[(2S)-octan-2-yl]formamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -204.264; AOFZLQPFVNKHSR; [M+H]+; 2-Ethylheptanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -205.913; NCMLFEXUCUKLTC; [M+H]+; N-Methyl-2-cyclohexylethanolamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -212.325; CGCDPLMLTIOADD; [M+H]+; N-Methyl-2-propylvaleramide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -219.651; JKUFWRDSSYNRPE; [M+H]+; 3-Propyl-2-hexanone oxime
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -219.931; GHLZUHZBBNDWHW; [M+H]+; Nonamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -220.920; QEOQBRVOQFQFEF; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -224.784; WIXWMTMSISERBV; [M+H]+; Nonanal, oxime
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -229.022; GRGNJBKJCVOFEO; [M+H]+; Novalketone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -229.906; NZMAJUHVSZBJHL; [M+H]+; Dibutylformamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -234.925; OYKSDWPYPAQPRX; [M+H]+; Ambcb9070586
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -239.105; WCPJVPPCOMEVQR; [M+H]+; 4-(2-Methylaminoethyl)cyclohexanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -239.679; ZRXAUOSECWYDMA; [M+H]+; (2R)-1-[(2S)-piperidin-2-yl]butan-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -242.818; UYPVPBFQQUHERE; [M+H]+; nonan-3-one oxime
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -254.116; NAXTXBAUPVGPMV; [M+H]+; 2,5-Dimethylpyrrolidine-1-propanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -254.241; QWDRYURVUDZKSG; [M+H]+; Ambcb4034760
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -254.659; HJVRJOCKISGMLI; [M+H]+; 2-(2-methylpropyl)oxan-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -256.785; HHONKRXRGXJUCW; [M+H]+; ACMC-20mgno
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -259.976; CDTAOSZEZXQTRJ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -266.866; RHULHUMGLDCWCP; [M+H]+; 1-Azepan-1-Yl-Propan-2-Ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -273.297; KXFQCMKAQXWNSL; [M+H]+; Ambcb4010638
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -274.651; JNSUUJLFWBSBME; [M+H]+; 1-Piperidinepropanol, 2-methyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -282.412; SSBJNXYJAHFKJQ; [M+H]+; 1-Piperidineethanol, a,a-dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -283.486; HZNNAMZSTNNZPR; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -297.300; UISZWADDKPLXNW; [M+H]+; 1-Butylpiperidin-3-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -307.983; KYEKSZMDGACCQD; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -309.436; JOHKCJPJMSCFBX; [M+H]+; 1-(1-methylpiperidin-2-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -352.574; CZRCDRZKRJGHGB; [M+H]+; Cyclohexanol, 1-[(dimethylamino)methyl]-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -371.595; MSYUGRASNIEUCW; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.286; NBXAPOVFSGOATB; [M+H]+; tert-Octylformamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -57.339; NZMAJUHVSZBJHL; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -144.098; NTYICSDTCGMBQM; [M+H]+; N,N-Bis(2-methylpropyl)formamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -175.534; QZMQDHNCNUGQSO; [M+H]+; Isovaleryl diethylamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -182.480; BPDCZYLPNNLOBD; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -188.341; ZBWPKQRQZDZVSF; [M+H]+; N-Octylformamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -188.426; HZNNAMZSTNNZPR; [M+H]+; Formyl-hexyl-dimethylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -189.188; NBXAPOVFSGOATB; [M+H]+; N-(1,1,3,3-Tetramethylbutyl)formamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -195.379; XGPJZKQGJWZWIM; [M+H]+; 4-Butoxypiperidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -195.815; MSRLXJWEQJQIJQ; [M+H]+; Formamide, N-(2-propylpentyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -199.407; BJXJCAMLWINIQS; [M+H]+; 2,2,4,4-tetramethyl-N-oxidopentan-3-imine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.769; NZMAJUHVSZBJHL; [M+H]+; nan
COMMENT: CONFIDENCE Level 3: Tentative candidate, N,N-dibutylformamide, NZMAJUHVSZBJHL-UHFFFAOYSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (1), MetFrag:MsfinderDB (2), MetFrag:PubchemLite (2);
CH$NAME: N,N-dibutylformamide
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C9H19NO
CH$EXACT_MASS: 157.146664
CH$SMILES: CCCCN(CCCC)C=O
CH$IUPAC: InChI=1S/C9H19NO/c1-3-5-7-10(9-11)8-6-4-2/h9H,3-8H2,1-2H3
CH$LINK: INCHIKEY NZMAJUHVSZBJHL-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:12975
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 12.021
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 158.153986
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0a4i-5900000000-f225469a15a454a904d3
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  53.9392776 31.0284 53.939980 1.2051 11.22 0.2024 41 ?
  55.0544422 41.4158 55.055150 0.8719 7.50 0.2412 44 f{C4H7}/3.92ppm,p-C5H13N1O1
  55.9346583 511.0063 55.935370 0.3933 151.31 -0.2499 52 ?
  57.0701235 131.3853 57.070840 0.7535 29.70 0.6738 51 f{C4H9}/4.32ppm,p-C5H11N1O1
  69.0699770 34.2257 69.070720 1.1872 8.55 0.2947 50 f{C5H9}/1.45ppm,p-C4H11N1O1
  70.0288468 40.1216 70.029590 1.0710 15.38 0.2183 37 f{C3H4N1O1}/1.52ppm,p-C6H16
  70.9579168 27.8068 70.958660 1.2825 10.47 -0.1769 37 ?
  71.9293620 47.9437 71.930105 1.0705 15.28 0.0521 46 ?
  72.0445221 303.8027 72.045265 0.4581 76.32 0.1271 52 f{C3H6N1O1}/1.83ppm,p-C6H14
  72.9372376 229.4992 72.937980 0.5210 68.36 -0.2124 52 ?
  74.9309097 46.7512 74.931650 1.0410 17.35 -0.1527 51 ?
  74.9376597 193.2614 74.938400 0.6138 60.10 -0.1457 52 ?
  75.0553449 39.5599 75.056085 0.9460 11.42 0.2297 48 ?
  75.9354312 43.0053 75.936170 1.1325 15.76 -0.2343 51 ?
  76.9329730 80.9672 76.933710 0.9229 29.36 -0.1559 51 ?
  78.9971077 139.4377 78.997840 0.8228 45.29 -0.0916 50 ?
  80.9450632 51.6618 80.945790 1.0377 22.64 -0.0065 45 ?
  89.9398286 64.6314 89.940515 1.0229 22.56 -0.1209 48 ?
  90.9476596 82.6008 90.948340 1.1105 26.68 -0.1792 45 ?
  95.0854876 60.1439 95.086140 1.0412 14.40 0.3278 52 f{C7H11}/-0.41ppm,p-C2H9N1O1
  97.0076223 191.8857 97.008260 0.8247 52.65 -0.1045 52 f{C8H1}/3.57ppm,p-C1H19N1O1
  97.0648128 33.9965 97.065450 1.3084 10.85 0.1989 46 f{C6H9O1}/0.22ppm,p-C3H11N1
  102.0913566 269.9313 102.091950 0.5093 68.51 0.8391 52 f{C5H12N1O1}/0.16ppm,p-C4H8
  106.9919767 190.0198 106.992520 0.7290 58.75 -0.0693 52 ?
  107.9504234 65.1052 107.950960 1.0838 21.18 -0.0323 51 ?
  113.9636180 40.1741 113.964110 1.1144 12.47 0.1142 47 ?
  114.0549687 93.7079 114.055460 1.4467 26.17 0.1986 51 ?
  115.9640546 227.5403 115.964530 0.7071 75.01 -0.0645 52 ?
  117.0698091 38.4330 117.070275 1.1788 10.70 0.1800 48 f{C9H9}/-0.58ppm,p-H11N1O1
  117.9595170 92.3952 117.959975 1.4412 32.61 -0.2121 46 ?
  125.0025453 313.8068 125.002935 0.6320 92.21 -0.0921 52 f{C9H1O1}/2.83ppm,p-H19N1
  125.9609604 51.9593 125.961340 1.0956 17.47 -0.1022 51 ?
  128.9508133 289.1200 128.951160 0.6126 89.95 -0.1471 52 ?
  130.9818467 45.1588 130.982170 1.0383 12.91 -0.0195 40 ?
  131.0854979 32.8968 131.085820 1.3197 9.47 0.5044 43 ?
  133.9746629 54.2954 133.974950 1.0450 22.12 -0.1615 37 ?
  135.9453867 133.4117 135.945650 1.0960 42.62 -0.1902 52 ?
  139.9822261 50.2323 139.982500 1.3502 17.63 -0.2611 45 ?
  146.9612925 137.4190 146.961585 0.9798 42.55 -0.0692 50 ?
  153.9559284 79.7841 153.956240 1.3056 29.54 -0.2029 47 ?
  157.1335296 34.1372 157.133850 1.3555 7.79 0.2402 41 ?
  157.9925722 106.1865 157.992895 1.4431 38.39 -0.3031 52 ?
  158.0964569 999.0000 158.096780 0.3479 0.00 0.3842 52 ?
  158.1539467 541.4923 158.154270 0.4236 125.40 1.0000 52 f{C9H20N1O1}/0.04ppm,p
  159.0998641 134.5290 159.100190 0.7354 17.01 0.4613 47 ?
  159.1573389 64.0049 159.157665 1.3886 18.20 0.6671 46 ?
PK$NUM_PEAK: 46
PK$PEAK: m/z int. rel.int.
  53.939278 31.03 31
  55.054442 41.42 41
  55.934658 511.01 511
  57.070124 131.39 131
  69.069977 34.23 34
  70.028847 40.12 40
  70.957917 27.81 27
  71.929362 47.94 47
  72.044522 303.80 303
  72.937238 229.50 229
  74.930910 46.75 46
  74.937660 193.26 193
  75.055345 39.56 39
  75.935431 43.01 43
  76.932973 80.97 80
  78.997108 139.44 139
  80.945063 51.66 51
  89.939829 64.63 64
  90.947660 82.60 82
  95.085488 60.14 60
  97.007622 191.89 191
  97.064813 34.00 33
  102.091357 269.93 269
  106.991977 190.02 190
  107.950423 65.11 65
  113.963618 40.17 40
  114.054969 93.71 93
  115.964055 227.54 227
  117.069809 38.43 38
  117.959517 92.40 92
  125.002545 313.81 313
  125.960960 51.96 51
  128.950813 289.12 289
  130.981847 45.16 45
  131.085498 32.90 32
  133.974663 54.30 54
  135.945387 133.41 133
  139.982226 50.23 50
  146.961293 137.42 137
  153.955928 79.78 79
  157.133530 34.14 34
  157.992572 106.19 106
  158.096457 999.00 999
  158.153947 541.49 541
  159.099864 134.53 134
  159.157339 64.00 64
//
